Friday, February 08, 2019 9:43:08 AM
https://finance.yahoo.com/news/sport-endurance-signs-letter-intent-130000875.html
BROOKLYN, N.Y., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (SENZ) (the “Company”), to be reincorporated as Better Choice Company, Inc., today announced that it has signed a Letter of Intent (“LOI”) to acquire Bona Vida Inc. (“Bona Vida”), an innovative emerging CBD platform, focused on developing a portfolio of brand and product verticals within the animal and human health and wellness space. Bona Vida will be exclusively focused on CBD derived from industrial hemp, with the goal of becoming the dominant worldwide player in this high growth industry.
“The potential acquisition of Bona Vida is a key step forward towards becoming a leader in the CBD pet space,” said David Lelong, Chief Executive Officer of Sport Endurance. “As part of our business strategy, we have been exploring opportunities to further develop a CBD-infused line of animal products. Bona Vida offers a range of trusted CBD products as well as expertise in formulation, research and development, manufacturing support, quality control, and company oversight that will prove to be extremely valuable as the Company continues to grow. Additionally, the integration of Bona Vida allows us to diversify our product development and distribution strategy in a way that will be synergistic with our proposed acquisition of TruPet, which offers its own unique product line and distribution channels.”
Damian Dalla-Longa, CEO of Bona Vida, said, “The Bona Vida team and I are pleased to be working with a team that shares the same vision and enthusiasm that I have for the pet CBD industry. We are at the beginning of a fundamental shift in the global acceptance of CBD as a lifestyle improvement product and with the passing of the Hemp Farming Act within the 2018 Farm Bill in December 2018, we see exciting new market opportunities opening for CBD-based wellness products across the board,” said Dalla-Longa. “We believe that positive regulatory tailwinds will continue to enhance market access for consumers and that industrial hemp is quickly becoming an agricultural commodity with almost limitless product alternatives.”
“Bona Vida strives to be the market leader in all of these verticals by deploying a contract manufacturing and distribution model that currently does not exist in the space. This will provide Bona Vida with a first-mover competitive advantage, help scale the business quickly and deliver maximum value to all shareholders,” said Dalla-Longa.
About Bona Vida Inc.
Bona Vida’s goal is to be the leading developer of a portfolio of brand and product verticals within the animal and adult health and wellness space and plans to become the preeminent player in the global hemp-derived CBD industry. Importantly, Bona Vida will only be sourcing CBD from industrial hemp. Bona Vida is developing and operating in the global hemp-derived CBD space with a focus on the following markets: Pets (dogs and cats), Veterinary, Livestock and human health and wellness. For more information, please visit: www.bonavida.com and @bonavidacbd on Facebook, Instagram and Twitter. Bona Vida can be reached at: info@bonavida.com.
Recent BTTR News
- Better Choice is Encouraged by the Potential DEA Reclassification of Marijuana • GlobeNewswire Inc. • 04/30/2024 08:00:00 PM
- Better Choice Company Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards • GlobeNewswire Inc. • 04/29/2024 08:15:00 PM
- Better Choice Company Board of Directors Authorize Stock Repurchase Program • GlobeNewswire Inc. • 04/16/2024 01:15:00 PM
- Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 04/12/2024 08:39:02 PM
- Better Choice Company Initiates Legal Action Against Alphia, a Portfolio Company of Private Equity Firm PAI • GlobeNewswire Inc. • 03/26/2024 01:15:00 PM
- Better Choice Company To Effectuate a Reverse Stock Split • GlobeNewswire Inc. • 03/08/2024 09:05:00 PM
- Better Choice to Explore Non-Equity Related Capital Solutions to Fund the R&D of its Domestic Animal Targeted GLP1 Supplement • GlobeNewswire Inc. • 03/04/2024 07:00:00 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/27/2024 04:10:05 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/16/2024 08:56:36 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:03:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 08:38:41 PM
- Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market • GlobeNewswire Inc. • 02/09/2024 02:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:59:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:59:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:59:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:58:55 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/18/2024 10:30:16 PM
- Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets • GlobeNewswire Inc. • 11/16/2023 07:30:00 PM
- BETTER CHOICE COMPANY, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS • GlobeNewswire Inc. • 11/13/2023 11:48:00 PM
- Better Choice Company, Inc. Announces Third Quarter 2023 Results • GlobeNewswire Inc. • 11/13/2023 11:36:44 PM
- Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs R&D Partnership Agreement for Development of GLP1 Supplement for Pets • GlobeNewswire Inc. • 11/08/2023 03:25:00 PM
- Better Choice Announces Partnership with Aimia Pet Health to Develop a GLP1 Supplement for its Halo Brand to Combat Obesity in Dogs and Cats • GlobeNewswire Inc. • 10/12/2023 06:45:00 PM
- Better Choice Company Receives NYSE American Notice • GlobeNewswire Inc. • 09/27/2023 08:29:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 06:17:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/26/2023 01:22:36 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM